Session Information
-
WCLC 2021
2021 World Conference on Lung Cancer
Presentation Date(s):- September 8 - 14, 2021
- Total Presentations: 1107
All times listed are in Mountain Time MDT (UTC-6:00)
PL - Plenary
ES - Education Session
OA - Oral Session
MA - Mini Oral Session
FP - Featured Posters
P - Posters
WS - Workshops
IS - Industry Symposium
MTE - Meet the Expert
BEDG - Brain Exchange Discussion Groups
September 8 Wed
Sep 8 Thursday
September 9 Thu
Sep 9 Friday
September 10 Fri
Sep 10 Saturday
September 11 Sat
Sep 11 Sunday
September 12 Sun
Sep 12 Monday
September 13 Mon
Sep 13 Tuesday
September 14 Tue
Sep 14
-
+
P24 - Liquid Biopsy and Other Non-invasive Diagnostic Modalities - Targeted Therapy
- 00:00 - 00:00
- 9/08/2021
- Location: ePoster Hall
- Not for CME Credit
- Type: Posters
- Track: Liquid Biopsy and Other Non-invasive Diagnostic Modalities
-
+
P24.03 - Dynamic Circulating Tumor DNA Interim Results From The ALKternate Clinical Trial
00:00 - 00:00 | Presenter: Malinda Itchins
- Abstract
Loading...
-
+
P52 - Novel Therapeutics and Targeted Therapies - KRAS
- 00:00 - 00:00
- 9/08/2021
- Location: ePoster Hall
- Not for CME Credit
- Type: Posters
- Track: Novel Therapeutics and Targeted Therapies
-
+
P52.03 - Efficacy of Sotorasib in KRAS p.G12C-Mutated NSCLC with Stable Brain Metastases: A Post-Hoc Analysis of CodeBreaK 100
00:00 - 00:00 | Presenter: Suresh Ramalingam
- Abstract
Loading...
-
+
ES04 - Antibody–Drug Conjugates: Current Status and Future Perspectives*
- 09:00 - 09:35
- 9/10/2021
- Location: Program Auditorium
- IASLC CME Accredited
- Type: Education Session
- Track: Novel Therapeutics and Targeted Therapies
*Full-length Educational talk will be available as pre-release content as of September 1. The Live Day Educational Sessions will feature brief summaries and extended live discussion with the presenters. Delegates are encouraged to watch the pre-released content prior to watching the live Educational Sessions.- Moderators:Maria Rosario García Campelo, Ana Gelatti
-
+
ES04.01 - Structure and Mechanism of Antibody Drug Conjugates
09:00 - 09:02 | Presenter: Bob T. Li
- Abstract
No abstract available for this presentation
-
+
MA14 - Pathologic Patterns, Genomic Alterations and Targeted Therapies in NSCLC
- 18:45 - 19:45
- 9/13/2021
- Location: Program Auditorium
- IASLC CME Accredited
- Type: Mini Oral
- Track: Predictive Tumor Based Assays/ Biomarkers/ Pathology
-
+
MA14.03 - Genomic Profiles and Potential Determinants of Response and Resistance in KRAS p.G12C-mutated NSCLC Treated With Sotorasib
18:55 - 19:00 | Presenter: Ferdinandos Skoulidis
- Abstract
Loading...
